haemophilia Archives -

Sanofi’s attempt to take on Roche with a ground-breaking approach to treating haemophilia has hit a setback after

Sanofi/Alnylam’s haemophilia drug hits another safety speed-bump

https://pharmaphorum.com/news/sanofi-alnylans-haemophilia-drug-hits-another-safety-speed-bump/

News/ News/ R&D

Novo Nordisk builds in haemophilia with Bluebird Bio gene editing deal

Phil Taylor bluebird bio, gene editing, genetic, Haematology, haemophilia, Novo Nordisk 0 Comment

Anxious not to be left behind in the haemophilia market, Novo Nordisk has forged an alliance with Bluebird

Novo Nordisk builds in haemophilia with Bluebird Bio gene editing deal

https://pharmaphorum.com/news/novo-nordisk-builds-in-haemophilia-with-bluebird-bio-gene-editing-deal/

Market Access/ News/ News

NHS reimburses Roche’s Hemlibra in new group of haemophilia patients

Richard Staines haemophilia, Rare diseases, Roche 0 Comment

NHS England has agreed to reimburse Roche’s Hemlibra (emicizumab) in a new group of patients with haemophilia A,

NHS reimburses Roche’s Hemlibra in new group of haemophilia patients

https://pharmaphorum.com/news/roche-hemlibra-haemophilia/

News/ News/ R&D

Catalyst’s rival to NovoSeven hits the mark in phase 2 haemophilia trial

Phil Taylor Catalyst Biosciences, gene therapy, Haematology, haemophilia, Novo Nordisk, Sangamo Therapeutics, Takeda, uniQure 0 Comment

Catalyst Biosciences is a step closer to challenging Novo Nordisk’s NovoSeven in the haemophilia A and B market

Catalyst’s rival to NovoSeven hits the mark in phase 2 haemophilia trial

https://pharmaphorum.com/news/catalysts-rival-to-novoseven-hits-the-mark-in-phase-2-haemophilia-trial/

News/ News/ R&D

BioMarin seeks haemophilia gene therapy approval after promising data

George Underwood BioMarin, gene therapy, haemophilia, valoctocogene roxaparvovec 0 Comment

BioMarin is set to file for approval for its haemophilia gene therapy valoctocogene roxaparvovec, after it achieved pre-specified

BioMarin seeks haemophilia gene therapy approval after promising data

https://pharmaphorum.com/news/biomarin-seeks-haemophilia-gene-therapy-approval-after-promising-data/

Patients/ Views & Analysis/ Views and analysis

The unmet needs of bleeding disorder patients

Dominic Tyer bleeding disorders, eyeforpharma, haemophilia 0 Comment

Ahead of eyeforpharma Philadelphia 2019, we talk to speaker and haemophilia advocate Michelle Rice about the changing landscape

The unmet needs of bleeding disorder patients

https://pharmaphorum.com/views-analysis-patients/the-unmet-needs-of-bleeding-disorder-patients/

News

EU expands use of Roche’s new haemophilia A drug

Richard Staines haemophilia, Roche 0 Comment

The European Commission has approved Roche haemophilia A drug Hemlibra for patients without factor VIII inhibitors, expanding the

EU expands use of Roche’s new haemophilia A drug

https://pharmaphorum.com/news/eu-expands-use-of-roches-new-haemophilia-a-drug/

News/ News/ Patients/ Top stories

Gene therapy firm BioMarin stages haemophilia musical

Richard Staines BioMarin, comms, haemophilia, Novo Nordisk, patients, Rare diseases, Roche, Shire 0 Comment

BioMarin Pharmaceutical has put on a stage musical to raise awareness about haemophilia, and determine whether creative expression

Gene therapy firm BioMarin stages haemophilia musical

https://pharmaphorum.com/news/gene-therapy-firm-biomarin-stages-haemophilia-musical/

Debates & Insight/ Insights/ Patients/ White Papers/ Whitepapers

How pharma can boost engagement by embracing support networks

louise.bellamy@pharmaphorum.com haemophilia, patient centricity, patient voice, pharma marketing, pharmaceutical branding, pharmaceutical industry marketing insights, support network 0 Comment

Connecting with patients has become a central plank in the pharma marketing playbook, but should companies be looking

How pharma can boost engagement by embracing support networks

https://pharmaphorum.com/patients/insights-patients/how-pharma-can-boost-engagement-by-embracing-support-networks/

Trending

haemophilia

Login